News & Articles

Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells

The drug aims to treat patients with myelodysplastic syndromes

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers

Gain insights on hot topics ranging from respiratory virus testing to nano and quantum materials and automated LC-MS/MS workflows

Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment

The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients

The novel lipid nanoparticles for mRNA delivery will enhance thermostability, biodegradability and safety, paving the way for new off-the-shelf therapies

VITROS Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies

Take lateral flow diagnostics to the next level with improved sensitivity for the future of IVDs

The Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets

Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand

Catch up on this on-demand webinar to discover how combining multiplexing with HTS could streamline your drug discovery

The self-collection kits facilitate raw saliva collection to aid global SARS-CoV-2 research and surveillance efforts

In this guest editorial, Michaël van der Jagt, CEO of Parx Materials, discusses how the human immune system can inspire innovation

The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity

The Panbio self-test features a minimally invasive nasal swab and delivers results in as early as 15 minutes with no instrumentation, using proven Abbott lateral flow technology